Adverse effect of unsp fibrinolysis-affecting drugs, sequela

This code signifies a long-term or residual condition resulting from an adverse reaction to a fibrinolysis-affecting drug, where the specific drug involved is not documented. These drugs include agents that promote or inhibit the breakdown of blood clots. The sequela indicates that the acute adverse effect has resolved, but a lasting consequence remains.

Use this code when a patient presents with a chronic or permanent health problem directly attributable to a past adverse effect of an unspecified fibrinolysis-affecting medication. This applies when the original adverse event has concluded, but its lingering impact requires ongoing management. Examples include persistent organ damage or chronic neurological deficits stemming from the drug reaction.

• Always assign an additional code to identify the specific nature of the sequela (e.g., chronic kidney disease, neurological deficit).
• Ensure documentation clearly links the current condition to a previous adverse effect of an unspecified fibrinolysis-affecting drug.
• Do not use this code for acute adverse effects; instead, use the appropriate acute adverse effect code from the T45.6- category.